Hematologic Diseases Clinical Trials in Hangzhou, Zhejiang
2 recruitingHangzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia
NeoplasmsHematologic Diseases
Zhejiang University20 enrolled1 locationNCT07257640
Recruiting
Phase 1Phase 2
CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases
NeoplasmsHematologic Diseases
Zhejiang University30 enrolled1 locationNCT05827835